IMA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
Cost of Revenue
0
0
0
0
Gross Profit
0
0
0
0
Operating Expenses
11.8M
-2.4%
12.1M
+42.0%
8.5M
-68.0%
26.6M
R&D
6.7M
+11.9%
6.0M
+82.1%
3.3M
-79.0%
15.6M
SG&A
5.1M
-16.4%
6.1M
+17.0%
5.2M
-52.6%
11.0M
Operating Income
-11784000
+2.4%
-12079000
-42.0%
-8504000
+68.0%
-26594000
EBITDA
-11784000
+2.4%
-12079000
-48.9%
-8111000
+69.7%
-26762000
Net Income
-10178000
+4.2%
-10619000
-53.7%
-6908000
+72.1%
-24779000
EPS (Basic)
$-0.63
+33.7%
$-0.95
+19.5%
$-1.18
+59.5%
$-2.91
EPS (Diluted)
$-0.63
+33.7%
$-0.95
+19.5%
$-1.18
+59.5%
$-2.91
Shares (Diluted)
16.2M
+44.2%
11.2M
+90.8%
5.9M
-33.2%
8.8M
ImageneBio (IMA) โ€” Financials